FindTrial
Sign In

Application of nalmefene in pediatric day surgery

Application of nalmefene in pediatric day surgery - randomized, double-blind, single-center study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020307
Enrollment
Unknown
Registered
2018-12-23
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

day surgery

Interventions

Group 2:nalmefene
Group 1:0.9% N.S

Sponsors

Children's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1-6 year-old children who schedule to day surgery as sac high ligation or high sheath ligation; 2. Children receive sufentanil analgesia.

Exclusion criteria

Exclusion criteria: 1. Children whose family member have not sign the informed consent; 2. Children with epilepsy; 3. Children with nalmefene allergy or other reasons not suitable for using nalmefene; 4. Children who have recently taken other drugs include analgesic,hormone drugs,drugs that affect airway reactivity.

Design outcomes

Primary

MeasureTime frame
None;RR;scale of pain;—

Secondary

MeasureTime frame
Removal time of laryngeal mask;EA;—

Countries

China

Contacts

Public ContactLongde Zhao

Children's Hospital of Nanjing Medical University

187211268zld@163.com+86 15850512162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026